Latest Regulatory Approval News

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Bowen Coking Coal maintained steady production and sales in Q3 2025 while slashing costs by a third through a new mining model, despite ongoing administration and receivership. The company generated positive operating cash flow and advanced key development projects.

Electro Optic Systems (EOS) reports a surge in contract backlog to $415 million, anchored by a landmark $125 million export order for a high-energy laser weapon. Despite a $34.3 million operating cash outflow in Q3, EOS is poised for growth with new defence contracts and product innovations.

Emperor Energy has secured a significant resource upgrade for its Judith Gas Field and raised $3.7 million to progress the Judith-2 appraisal well, targeting commercial gas supply in a tightening East Coast market.

Blue Energy has been granted a critical petroleum lease in Queensland and completed a $5.8 million capital raise, positioning itself to meet rising gas demand aligned with the Queensland Government’s new Energy Roadmap.

Clarity Pharmaceuticals has bolstered its financial position with a $203 million institutional placement and reported positive Phase II trial results for its lead prostate cancer diagnostic, Cu-SAR-bisPSMA. The company also expanded its pipeline with promising preclinical data on a pan-cancer agent and secured a key copper-67 supply agreement to support future commercialisation.

The Star Entertainment Group reported a 5% revenue increase in Q1 FY26 and a halving of its EBITDA loss, while navigating regulatory challenges and advancing a major joint venture exit.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Comet Ridge has made significant progress in its Mahalo Gas Hub development, advancing engineering design and securing independent certification of substantial gas reserves. The company is moving closer to a Final Investment Decision amid ongoing regulatory and commercial negotiations.

Micro-X Ltd has secured its largest-ever $3.3 million Rover Plus order from Malaysia’s Ministry of Health and is progressing critical Head CT imaging trials, supported by a $4.4 million government grant.

ABx Group Limited reports strong progress in rare earth extraction and clean chemical production, backed by strategic investments and a recent $3 million capital raise.

Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.